Pfizer Inc. (BCBA:PFE)

Argentina flag Argentina · Delayed Price · Currency is ARS
9,870.00
+190.00 (1.96%)
Dec 5, 2025, 4:59 PM BRT
41.40%
Market Cap 213.56T
Revenue (ttm) 83.41T
Net Income (ttm) 13.06T
Shares Out n/a
EPS (ttm) 2,293.32
PE Ratio 16.36
Forward PE 8.75
Dividend 340.88 (3.45%)
Ex-Dividend Date Nov 7, 2025
Volume 15,832
Average Volume 29,099
Open 9,700.00
Previous Close 9,680.00
Day's Range 9,610.00 - 9,870.00
52-Week Range 5,990.00 - 10,800.00
Beta 0.43
RSI 59.02
Earnings Date Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

There is no news available yet.